关于胰腺癌风险因素的病例对照试验:系统审查和元分析
Yan Yang1, Jianwei Shi2, Jiaoling Huang2
1School of Economics & Management, Tongji University, Shanghai, China.
Iranian journal of public health
|September 25, 2023
概括
吸烟,糖尿病,胰腺癌 (PC) 的家族史和慢性胰腺炎是PC的关键独立风险因素. 识别这些因素对于早期检测和改善患者结果至关重要.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 胰腺癌 (PC) 是一个重要的健康问题,有许多研究的风险因素.
- 以前的研究集中在PC的个体风险因素上.
- 需要对多个独立的风险因素有全面的了解.
研究的目的:
- 综合现有关于胰腺癌风险因素的研究.
- 识别和量化PC的多个独立风险因素.
- 为高风险群体的识别和预防战略提供数据.
主要方法:
- 在2020年2月28日之前发表的英语和中文文章的系统审查.
- 使用固定效应模型进行元分析.
- 使用RevMan 5.3.3计算的95%信心区间 (CI) 的聚合赔率比率 (OR).
主要成果:
- 吸烟显著增加了PC风险 (OR: 1.76,95% CI: 1.61-1.92).
- 糖尿病是一个强大的独立风险因素 (OR:2.69,95% CI:2.52-2.88).
- 家庭PC病史 (OR:2.58,95%CI:2.13-3.11) 和慢性胰腺炎 (OR:5.84,95%CI:3.63-9.41) 也是显著的独立风险因素.
结论:
- 吸烟,糖尿病,家族PC病史和慢性胰腺炎已被证实是PC的独立风险因素.
- 这些发现对于识别患PC风险较高的人来说至关重要.
- 了解这些因素可以指导干预措施,以减少PC发病率并改善患者的预后.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
108
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
108
01:24Chronic Pancreatitis I: Introduction
106
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
106
01:12Hazard Ratio
152
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
152
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
145
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
145
02:59Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
01:21Cancer Survival Analysis
380
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380